Showing results (911-920 of 936) with videos related to

Sort By:
Pageof 94
Lancet (London, England)|September 4, 2021
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)Amy Flaxman, Natalie G Marchevsky, Daniel Jenkin, et al.
Clinical and Experimental Immunology|February 2, 2023
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trialsMerryn Voysey, Amy Flaxman, Jeremy Aboagye, et al.
Nature|July 31, 2020
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaquesNeeltje van Doremalen, Teresa Lambe, Alexandra Spencer, et al.
The Lancet. HIV|August 20, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trialShabir A Madhi, Anthonet L Koen, Alane Izu, et al.
NPJ Vaccines|July 23, 2025
Nipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public healthRebecca K McLean, Miriam Pedrera, Nazia Thakur, et al.
NPJ Vaccines|August 15, 2020
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19Simon P Graham, Rebecca K McLean, Alexandra J Spencer, et al.
The Lancet. Microbe|January 13, 2025
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trialsNavin Venkatraman, Alfred B Tiono, Georgina Bowyer, et al.
Communications Biology|July 27, 2021
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge modelsTeresa Lambe, Alexandra J Spencer, Kelly M Thomas, et al.
Nature Medicine|December 18, 2020
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trialKatie J Ewer, Jordan R Barrett, Sandra Belij-Rammerstorfer, et al.
NPJ Vaccines|May 11, 2021
ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferretsGlenn A Marsh, Alexander J McAuley, Gough G Au, et al.
Pageof 94